MedTrace Logo

Reconstruction of Peri-implant Osseous Defects: A Randomized Trial

NCT02406001 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 70

Last updated 2015-04-01

No results posted yet for this study

Summary

The purpose of this randomized trial was to compare reconstructive surgery of advanced peri-implant intra-osseous defects with porous titanium granules (PTG/Test) to open flap debridement (OFD/Control) in a non-submerged technique over 6 months.

Conditions

  • Peri-implantitis

Interventions

DEVICE

Tigran PTG

Open Flap Debridement

PROCEDURE

Surgical intervention

Open Flap Debridement

Sponsors & Collaborators

  • Tigran Technologies AB

    lead INDUSTRY

Principal Investigators

  • Stefan Renvert, Prof · Dep of Health Sciences Univ of Kristianstad Sweden

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-06-30
Primary Completion
2014-01-31
Completion
2014-06-30

Countries

  • Sweden

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02406001 on ClinicalTrials.gov